Table 1:
Subject | Age | PI-RADS v2 lesion score | Radiologic lesion location | PSA (ng/mL) | Gleason Grade Group | Pathology Specimen Type | Clinical Risk Group |
---|---|---|---|---|---|---|---|
1 | 59 | 5 | Right TZ and PZ | 7.8 | 2 | Biopsy (Systematic) | FIR |
2 | 54 | 5 | Right PZ | 10.6 | 3 | Biopsy (Systematic), Radical Prostatectomy | UIR |
3 | 71 | 5 | Right PZ and TZ | 4.0 | 5 | Biopsy (Systematic and Targeted), Radical Prostatectomy | HR |
4 | 72 | 5 | Right PZ | 5.7 | 2 | Biopsy (Systematic) | UIR |
5 | 54 | 5 | Right PZ | 7.3 | 3 | Biopsy (Systematic), Radical Prostatectomy | HR |
6 | 63 | 5 | Right PZ | 16.8 | 3 | Biopsy (Systematic), Radical Prostatectomy | HR |
7 | 74 | 5 | Right PZ | 29.3 | 5 | Biopsy (Systematic) | HR |
8 | 53 | 4 | Left PZ | 8.0 | 1 | Biopsy (Systematic), Radical Prostatectomy | FIR |
9 | 66 | 4 | Right PZ | 8.7 | 3 | Biopsy (Systematic and Targeted) | UIR |
10 | 67 | 5 | Left PZ | 4.6 | 2 | Biopsy (Systematic and Targeted) | FIR |
11 | 62 | 5 | Left PZ | 14.0 | 3 | Biopsy (Systematic), Radical Prostatectomy | HR |
12 | 74 | 4 | Left PZ | 4.4 | 3 | Biopsy (Systematic and Targeted), Radical Prostatectomy | UIR |
13 | 50 | 3 | Left PZ | 4.3 | 2 | Biopsy (Systematic), Radical Prostatectomy | HR |
14 | 65 | 4 | Right TZ | 8.0 | 1 | Biopsy (Systematic) | LR |
15 | 81 | 5 | Anterior TZ | 8.5 | 2 | Biopsy (Systematic and Targeted) | FIR |
16 | 77 | 5 | Right PZ | 3.5 | 4 | Biopsy (Systematic), Radical Prostatectomy | HR |
17 | 70 | 4 | Left PZ | 7.4 | 2 | Biopsy (Systematic and Targeted) | FIR |
18 | 58 | 4 | Left PZ | 7.4 | 2 | Biopsy (Systematic), Radical Prostatectomy | UIR |
19 | 62 | 4 | Left PZ | 5.0 | 1 | Biopsy (Systematic) | LR |
20 | 68 | 4 | Right PZ | 5.9 | 5 | Biopsy (Systematic and Targeted), Radical Prostatectomy | HR |
21 | 64 | 5 | Midline to Right TZ | 8.6 | 2 | Biopsy (Systematic and Targeted) | FIR |
22 | 51 | 5 | Diffuse PZ | 33.0 | 5 | Biopsy (Systematic) | VHR |
23 | 51 | 3 | Right TZ | 5.4 | 3 | Biopsy (Systematic), Radical Prostatectomy | UIR |
PI-RADS v2: Prostate Imaging – Reporting and Data System, version 2; PZ: peripheral zone of the prostate; TZ: transition zone of the prostate; PSA: prostate-specific antigen; FIR: Favorable intermediate risk; UIR: Unfavorable intermediate risk; HR: High risk; VHR: Very high risk.